FDA has classified the following indications as “possibly” effective: For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis. May also be useful as…
Each Tablet contains: Atropine Sulfate. USP.0.0194 mg Hyoscyamine Sulfate. USP.0.1037 mg Scopolamine Hydrobromide. USP.0.0065 mg Phenobarbital. USP.16.2 mg. Inactive ingredients: Anhydrous Lactose. Calcium Stearate. Colloidal Silicon Dioxide. Corn…
Each Tablet contains: Atropine Sulfate. USP.0.0194 mg Hyoscyamine Sulfate. USP.0.1037 mg Scopolamine Hydrobromide. USP.0.0065 mg Phenobarbital. USP.16.2 mg. Inactive ingredients: Anhydrous Lactose. Calcium Stearate. Colloidal Silicon Dioxide. Corn…
Each Tablet contains: Atropine Sulfate. USP.0.0194 mg Hyoscyamine Sulfate. USP.0.1037 mg Scopolamine Hydrobromide. USP.0.0065 mg Phenobarbital. USP.16.2 mg. Inactive ingredients: Anhydrous Lactose. Calcium Stearate. Colloidal Silicon Dioxide. Corn…
REZUROCK is indicated for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2022. All Rights Reserved.